Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 118 publications
Spatial Regulation of Preameloblast Development in Response to Distal Mouse Incisor Injury.
Journal: Calcified tissue international
Published: February 26, 2026
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer.
Journal: Nature medicine
Published: November 25, 2025
Cell-resolved high-dimensional imaging analysis, therapeutic modeling, and a Phase Ib clinical study establish BCL-2 as a target across heterogeneous CRPC subtypes.
Journal: bioRxiv : the preprint server for biology
Published: July 17, 2025
Single-cell imaging analysis, therapeutic modeling and a Phase Ib trial validate BCL-2 as a target across heterogeneous castration-resistant prostate cancer.
Journal: Signal transduction and targeted therapy
Published: July 17, 2025
LODESTAR: A Single-Arm Phase II Study of Rucaparib in Solid Tumors With Pathogenic Germline or Somatic Variants in Homologous Recombination Repair Genes.
Journal: JCO precision oncology
Published: July 09, 2025
Disrupted molecular glue complex drives RAS inhibitor resistance.
Journal: Cell
Published: June 03, 2025
Increasing Cancer Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient Survival.
Journal: bioRxiv : the preprint server for biology
Published: June 03, 2025
Impact of Amelogenesis Imperfecta on Junctional Epithelium Structure and Function.
Journal: Biology
Published: May 08, 2025
ASO Author Reflections: Intraoperative Radiation Therapy (IORT): Near Dead in the USA.
Journal: Annals of surgical oncology
Published: May 08, 2025
HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic Implications.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 02, 2025
Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 04, 2025
Last Updated: 09/26/2026